ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India
21 janv. 2025 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, is pleased to announce the opening of a...
Medical Lasers Market Size is Projected to Reach USD 12.02 billion by 2033, Growing at a CAGR of 9.10%: Straits Research
16 janv. 2025 20h15 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Medical lasers are light-emitting devices used for treating or removing tissues. Non-ionizing radiation decreases blood loss, alleviates...
Cytrellis Biosystems launches Updated Next-Generation Skin Removal Treatment ellacor® 2.0, fueled by new leadership and financing
07 janv. 2025 08h15 HE
|
Cytrellis Bioscience
Cytrellis marks new era of growth with the launch of ellacor 2.0, fueled by the completion of new financing and theappointment of Dr. Denise Dajles as CEO.
Chemical Peel Market Report 2024 - Global Forecasts to 2029: Rising Demand for Skin Rejuvenation Procedures Bolster Growth
03 janv. 2025 04h39 HE
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Chemical Peel Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The chemical peel market is anticipated...
Dermatology Treatment Devices Market Size Set for Explosive Growth, With Projections Indicating $ 21.86 billion by 2031 | The Insight Partners
17 déc. 2024 06h51 HE
|
The Insight Partners
US & Canada, Dec. 17, 2024 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the Global Dermatology Treatment Devices Market is expected to reach US$ 21.86...
Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million
13 déc. 2024 14h55 HE
|
Palvella Therapeutics Inc.
Palvella Therapeutics to debut on Nasdaq under the ticker symbol “PVLA” as a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a platform for...
Inflation Reduction Act Likely to Shape Specialty Prescribing Decisions in 2025, According to Spherix Global Insights
10 déc. 2024 09h59 HE
|
Spherix Global Insights
EXTON, PA, Dec. 10, 2024 (GLOBE NEWSWIRE) -- In 2022, the U.S. Congress enacted the Inflation Reduction Act (IRA), a landmark piece of legislation aimed at addressing various national priorities,...
ViaDerma Announces Significant 2024 Achievements and International Expansion
10 déc. 2024 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, proudly announces the completion of a...
AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer
09 déc. 2024 07h03 HE
|
AiViva Biopharma
AIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC) COSA MESA, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- AiViva Biopharma...
Derm-Biome Pharmaceuticals adds Dr. Jerry Tan, internationally renowned expert in acne and acne scarring, to its Scientific Advisory Board
25 nov. 2024 10h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver-based biopharmaceutical company developing safe and highly effective topical treatments...